These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15088897)

  • 1. Prediction of lymph node metastasis based on p53 and nm23-H1 expression in muscle invasive grade III transitional cell carcinoma of bladder.
    Park DS; Lee YT; Lee JM
    Adv Exp Med Biol; 2003; 539(Pt A):67-85. PubMed ID: 15088897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between p53 overexpression and lymph node metastases in clinical stage t2 and t3a transitional cell bladder carcinoma.
    Uygur MC; Yaman I; Kutluay L; Altuğ U; Erol D
    J Exp Clin Cancer Res; 1999 Sep; 18(3):391-5. PubMed ID: 10606186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivities of human nonmetastatic clone 23 and p53 products are disassociated and not good predictors of lymph node metastases in early-stage cervical cancer patients.
    Tee YT; Wang PH; Ko JL; Chen GD; Chang H; Lin LY
    Eur J Gynaecol Oncol; 2007; 28(1):18-22. PubMed ID: 17375700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
    Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
    Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.
    Khaled HM; Bahnassy AA; Raafat AA; Zekri AR; Madboul MS; Mokhtar NM
    BMC Cancer; 2009 Jan; 9():32. PubMed ID: 19171060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
    Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
    Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
    Zhou Y; Xu A; Ling X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
    Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
    Tannapfel A; Köckerling F; Katalinic A; Wittekind C
    Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.
    Shariat SF; Zlotta AR; Ashfaq R; Sagalowsky AI; Lotan Y
    Mod Pathol; 2007 Apr; 20(4):445-59. PubMed ID: 17384651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence?
    Feil G; Krause FS; Zumbraegel A; Wechsel HW; Bichler KH
    Adv Exp Med Biol; 2003; 539(Pt A):99-109. PubMed ID: 15088899
    [No Abstract]   [Full Text] [Related]  

  • 15. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
    Tannapfel A; Katalinic A; Köckerling F; Wittekind C
    Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
    Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
    Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
    Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M
    Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
    Kim KM; Lee A; Chae HS; Shim SI
    J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of p53 Expression Intensity in Urothelial Cancers.
    Qamar S; Inam QA; Ashraf S; Khan MS; Khokhar MA; Awan N
    J Coll Physicians Surg Pak; 2017 Apr; 27(4):232-236. PubMed ID: 28492153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.